Inventor · disambiguated record
Andrew A. Raubitschek
Also filed as: RAUBITSCHEK ANDREW · RAUBITSCHEK ANDREW A
10 granted patents·1 pending application·1,354 citations·filing 1985–2017
92Inventor score
Top patents by PatentIndex Score
11 records- 0197US7446179B2CD19-specific chimeric T cell receptorHOPE CITY·Filed 2001·Granted Nov 4, 2008·453 cites·5 claims
- 0297US6410319B1CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignanciesHOPE CITY·Filed 1999·Granted Jun 25, 2002·719 cites·22 claims
- 0393US7776330B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2007·Granted Aug 17, 2010·25 cites·9 claims
- 0489US5844241ASystem and method for determining internal radioactivity and absorbed dose estimatesHOPE CITY·Filed 1996·Granted Dec 1, 1998·101 cites·9 claims
- 0587US7273608B2Humanized anti-CEA T84.66 antibody and uses thereofHOPE CITY·Filed 2005·Granted Sep 25, 2007·10 cites·6 claims
- 0686US7727525B2Engineered anti-CD20 antibody fragments for in vivo targeting and therapeuticsHOPE CITY·Filed 2007·Granted Jun 1, 2010·7 cites·5 claims
- 0781US9701754B1Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2010·Granted Jul 11, 2017·2 cites·2 claims
- 0879US9765155B2Covalent disulfide-linked diabodies and uses thereofWU ANNA M·Filed 2012·Granted Sep 19, 2017·2 cites·1 claims
- 0975US4677070APseudomonas aeruginosa exotoxin A antibodies, their preparation and useCETUS CORP·Filed 1985·Granted Jun 30, 1987·32 cites·3 claims
- 1062US2018155449A1Covalent disulfide-linked diabodies and uses thereofHOPE CITY·Filed 2017·Application pending·0 cites
- 1137US4950598AProcess for making T cell hybridomasUNIV LELAND STANFORD JUNIOR·Filed 1985·Granted Aug 21, 1990·3 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →